- Home
- HCWB vs ABTS Comparison
HCWB vs ABTS Comparison
Compare HCWB & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- ABTS
- Stock Information
- Founded
- HCWB 2018
- ABTS 2010
- Country
- HCWB United States
- ABTS Hong Kong
- Employees
- HCWB N/A
- ABTS N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- ABTS Computer Software: Programming Data Processing
- Sector
- HCWB Health Care
- ABTS Technology
- Exchange
- HCWB Nasdaq
- ABTS Nasdaq
- Market Cap
- HCWB 17.2M
- ABTS 15.9M
- IPO Year
- HCWB 2021
- ABTS N/A
- Fundamental
- Price
- HCWB $0.39
- ABTS $0.41
- Analyst Decision
- HCWB
- ABTS
- Analyst Count
- HCWB 0
- ABTS 0
- Target Price
- HCWB N/A
- ABTS N/A
- AVG Volume (30 Days)
- HCWB 18.3M
- ABTS 44.7K
- Earning Date
- HCWB 03-31-2025
- ABTS 12-31-2024
- Dividend Yield
- HCWB N/A
- ABTS N/A
- EPS Growth
- HCWB N/A
- ABTS N/A
- EPS
- HCWB N/A
- ABTS N/A
- Revenue
- HCWB $3,495,990.00
- ABTS $5,343,888.00
- Revenue This Year
- HCWB $229.19
- ABTS N/A
- Revenue Next Year
- HCWB N/A
- ABTS N/A
- P/E Ratio
- HCWB N/A
- ABTS N/A
- Revenue Growth
- HCWB 22.27
- ABTS 3970.67
- 52 Week Low
- HCWB $0.21
- ABTS $0.38
- 52 Week High
- HCWB $2.52
- ABTS $1.06
- Technical
- Relative Strength Index (RSI)
- HCWB 48.72
- ABTS 40.07
- Support Level
- HCWB $0.38
- ABTS $0.40
- Resistance Level
- HCWB $0.42
- ABTS $0.46
- Average True Range (ATR)
- HCWB 0.09
- ABTS 0.04
- MACD
- HCWB -0.00
- ABTS -0.00
- Stochastic Oscillator
- HCWB 4.48
- ABTS 11.00
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations.